Company Filing History:
1 out of 28 
1 out of 223 
1 out of 489 
Years Active: 2023
Title: Inventor Spotlight: Hans De Haard
Introduction
Hans De Haard, based in Ghent, Belgium, is an innovative inventor known for his significant contributions to the field of biotechnology. With a focus on medical applications, De Haard has developed intellectual property that has the potential to impact therapeutic strategies.
Latest Patents
De Haard holds a patent for Galectin-10 antibodies, which describes antagonists, particularly antibodies and their binding fragments, that target the protein galectin-10. This invention is particularly notable as the galectin-10 antagonists can disrupt the crystallization of galectin-10, offering potential therapeutic benefits for diseases associated with the formation of Charcot-Leyden crystals (CLCs).
Career Highlights
Throughout his career, Hans De Haard has worked with notable companies in the biotechnology sector, including Argenx and VIB (Vlaamse Instituut voor Biotechnologie). His involvement with these organizations highlights his expertise and the relevance of his work in advancing biotechnological innovations.
Collaborations
De Haard has collaborated with accomplished professionals in the field, including Jean-Michel Percier and Christophe Blanchetot. These partnerships signify the importance of teamwork in driving forward groundbreaking research and development initiatives.
Conclusion
As a dedicated inventor, Hans De Haard continues to make strides in his field, leveraging his patent for Galectin-10 antibodies to further understand and address complex health conditions. His work reflects the innovative spirit that drives the biotechnology sector forward.